CVS Health Reports Strong Fourth Quarter and Full-year 2022 Results

CVS Health Corporation (NYSE: CVS) today announced operating results for the three months and year ended December 31, 2022. FOURTH QUARTER HIGHLIGHTS Total revenues increased to $83.8 billion, up 9.5% compared to prior year GAAP diluted EPS of $1.75 and Adjusted EPS of $1.99...